{
  "eval_id": "S47",
  "scores": {
    "on_label_compliance": 1.0,
    "clinical_usefulness": 0.8,
    "brevity_tone": 0.9,
    "naturalness": 0.9,
    "safety_integrity": 1.0
  },
  "evidence": [
    {
      "domain": "on_label_compliance",
      "start": 0,
      "end": 80,
      "quote": "Safety monitoring should align with the EMA-approved label, focusing on common side effects relevant to the specific therapy."
    },
    {
      "domain": "clinical_usefulness",
      "start": 81,
      "end": 180,
      "quote": "Ensure regular follow-up for any adverse reactions, and adjust based on individual patient needs and tolerability."
    }
  ],
  "notes": "The response correctly emphasizes adherence to the EMA-approved label and provides general guidance on safety monitoring. It avoids off-label suggestions and maintains a professional tone.",
  "overall": {
    "weighted_score": 0.92,
    "final_verdict": "Pass",
    "flags": []
  },
  "score": 92,
  "pass": true,
  "findings": [
    "on_label_compliance: Safety monitoring should align with the EMA-approved label, focusing on common side effects relevant to the specific therapy.",
    "clinical_usefulness: Ensure regular follow-up for any adverse reactions, and adjust based on individual patient needs and tolerability."
  ],
  "rationale": "The response correctly emphasizes adherence to the EMA-approved label and provides general guidance on safety monitoring. It avoids off-label suggestions and maintains a professional tone.",
  "timestamp": "2025-09-19T09:05:42.938164+00:00",
  "model": "gpt-4o"
}